Page 20 - Sanket Koul

Booster dose: India inches closer to regulatory framework for OTC drugs

DTAB has accepted sub-panel recommendation on OTC drugs list

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

The company's revenue from operations also rose to Rs 603 crore in Q4FY25, a 10.5 per cent Y-o-Y growth from Rs 545 crore reported in Q4FY24

SS Innovations lists on Nasdaq; shares trade under 'SSII' ticker

The trading commences on April 25, with the company's shares listed under the ticker symbol 'SSII'

Patent loss led to rise in prescriptions of new generation diabetes drugs

Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions

Suraksha Group to invest Rs 5,500 crore for completing 20,000 units

Execs confident of delivering all stalled towers within 40 months

Delhi NCR residential property prices up 81% in five years: Report

Greater Noida, Noida recorded over 90% price appreciation after pandemic as unsold stock drops

Centre launches standard curriculum for ten allied healthcare professions

Aims mandatory implementation of curriculum in allied healthcare institutes by 2026

Office completions dip 13% due to delays in OCs, project timelines: Report

Cushman & Wakefield report states robust leasing, low supply in most markets helped to bring drop in vacancy rates

CDSCO flags spurious batch of Telma, 131 other drugs fail quality tests

One of the popular hypertension medication brands Telma 40 samples were found to be spurious in raids across locations

Aster DM Healthcare gets CCI go-ahead for merger with Quality Care India

Combined entity to be among top 3 hospital chains in India with more than 10,000 beds across 27 cities

Green office inventory to touch 700 msf in next two to three years

Currently, two-thirds of Grade A office stock is already green-certified across the top six cities, with these buildings having higher occupancy levels at 80 to 90 per cent

IIT Delhi UG students get 850 unique job offers in 2025, highest in 3 years

Recruiters making double-digit offers to undergraduate students on campus this year include several large firms across sectors

Eli Lilly's first weight-loss pill shows success in initial Phase 3 trials

Lilly CEO says if approved, drug could be manufactured and launched at scale globally

CCPA issues notices to coaching centres for false claims, unfair practices

CCPA stated that the action pertains to institutions offering coaching for the Joint Entrance Examination (JEE) and National Eligibility-cum-Entrance Test (NEET)

NIIT acquires Coimbatore-based deep skilling training provider iamneo

Under the agreement, NIIT will acquire the remaining 30 per cent shareholding in phases from iamneo's promoters in subsequent tranches over the next five years

Zydus, Lupin shares fall over US court ruling in Myrbetriq patent case

Companies say they are in process of assessing impact of order on operations

CDSCO halts manufacture, sale, distribution of 35 FDCs over safety concerns

The list of unapproved FDCs includes antidiabetics, antibiotics, painkillers, infertility medications and nutritional supplements

After New York, Gurugram to house second Trump residential project

Gurugram to become first city outside US to have two Trump residential projects

Ujala Cygnus to acquire around 60% stake in Punjab hospital chain

Ujala Cygnus plans to expand further in northern India, to focus on super speciality units

How Indian students' hunt for new destination takes a fresh route

With stricter policies dampening US dream, Germany, Ireland, New Zealand emerge as new choices